Toggle Main Menu Toggle Search

Open Access padlockePrints

microRNA-324 mediates bone homeostasis and the regulation of osteoblast and osteoclast differentiation and activity

Lookup NU author(s): Dan Hayman, Dr Francesca Johnson de Sousa Brito, Hua LinORCiD, Yao Hao, Rachel Pearson, Dr Jamie Soul, Dr Katarzyna PirogORCiD, Dr Matthew Barter, Professor David YoungORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 The Author(s). MicroRNAs (miRNAs) modulate the expression of other RNA molecules. One miRNA can target many transcripts, allowing each miRNA to play key roles in many biological pathways. Defects in bone homeostasis result in common age-related diseases including osteoporosis. Serum levels of miR-324-3p positively correlate with several features of bone maintenance. In contrast here, using in vivo micro-computed tomography and histology, global miR-324-null mice demonstrated increased bone mineral density and both trabecular and cortical thickness, with effect magnitudes increasing with age. The bone marrow of miR-324-null mice had reduced lipid content while TRAP staining revealed a decrease in osteoclasts, with histomorphometry demonstrating an increased rate of bone formation. Ex vivo assays showed that the high bone mass phenotype of miR-324-null mice resulted from both increased osteoblast activity and decreased osteoclastogenesis. RNA-seq analysis of osteoblasts, osteoclasts and bone marrow macrophages and target validation assays identified that the osteoclast fusion regulator Pin1 and the master osteogenic regulator Runx2 were targets of miR-324-5p in osteoclast lineage cells and osteoblasts, respectively. Indeed, in vitro Runx2 overexpression recapitulated the increased osteogenesis and decreased adipogenesis phenotype observed in vivo by the loss of miR-324. Overall, these data demonstrate the importance of miR-324 in bone homeostasis by regulating aspects of both bone formation and remodelling. Elucidation of pathways regulated by miR-324 offer promise for the treatment of bone diseases such as osteoporosis.


Publication metadata

Author(s): Hayman DJ, Johnson de Sousa Brito FM, Lin H, Prior A, Charlesworth G, Hao Y, Pearson RD, Soul J, Clark IM, Pirog KA, Barter MJ, van't Hof RJ, Young DA

Publication type: Article

Publication status: Published

Journal: Bone

Year: 2025

Volume: 190

Print publication date: 01/01/2025

Online publication date: 09/10/2024

Acceptance date: 03/10/2024

Date deposited: 21/10/2024

ISSN (electronic): 1873-2763

Publisher: Elsevier Inc.

URL: https://doi.org/10.1016/j.bone.2024.117273

DOI: 10.1016/j.bone.2024.117273

Data Access Statement: Data will be made available on request.

PubMed id: 39383985


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
22043VERSUS Arthritis (formerly Arthritis Research UK)
19424
JGW Patterson Foundation
JXR 10641
Medical Research Council
MR/P020941/1
NIHR Newcastle Biomedical Research
R476/0516Dunhill Medical Trust
Versus Arthritis

Share